Articles On Sigma Healthcare (ASX:SIG)

BGH increases holdings in Virtus Health as battle for fertility company escalates Out of favour health stocks attract attention of big money managers ASX gold stocks see changes in substantial holdings as price of precious metal falls in m...

World Overnight SPI Overnight 7299.00 – 25.00 – 0.34% S&P ASX 200 7347.00 – 88.00 – 1.18% S&P500 4155.38 + 23.45 0.57% Nasdaq Comp 12536.02 + 201.38 1.63% DJIA 33061.50 + 84.29 0.26% S&P500 VIX 32.34 – 1.06 – 3.17%...

The Vanguard Australian Shares Index ETF (ASX: VAS) is an exchange-traded fund (ETF) that’s invested in ASX shares. Could it be a good time to invest in the VAS ETF at the current price? It tracks the S&P/ASX 300 Index (ASX: XKO), whic...

ShareCafeThe Week that Was – March 28-April 1, 2022 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do...

Highlights Companies like Beacon Minerals, Cyclopharm and Sigma Healthcare will be turning ex-dividend on Monday (4 April 2022). The ex-dividend date is usually one day (business day) before the record date for stocks. Investors get t...

The Wesfarmers Ltd (ASX: WES) share price underperformed the broader market in March despite the company signing the deed to its latest acquisition. That’s right, the retail conglomerate is now the official owner of the ASX-listed (though,...

A lot of money has been paid into shareholder pockets via dividends this month and this trend is set to continue in April. But in order to be eligible to receive these dividends, you’ll need to be on a company’s share register prior to the...

Following FY21 results for Sigma Healthcare brokers see an uncertain outlook for near-term earnings. -Sigma Healthcare’s FY21 loss and weak cash flow-Issues with software may continue to weigh on earnings-Forward guidance withdrawn-Potentia...

ShareCafeSIG – Citi rates the stock as Neutral Following FY22 results (January year end) Citi believes near-term earnings visibility for Sigma Healthcare is limited. Also, given ongoing issues with ERP implementation and distribution centre...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Wednesday. In afternoon trade, the benchmark index is up 0.75% to 7,520.5 points. Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((BKW)) - Brickworks ((KMD)) - KMD Brands ((NHC)) - New Hope ((PMV)) - Premier Investments ((SIG)) - Sigma Healthcare ((TUA)) - Tuas ((SOL)) - WH Soul Pattinson Check it...

ShareCafeSigma Ready to Put the Past Behind It Sigma Healthcare believes it is in the final phase of its remaking and ready to show that it has overcome distribution and sales problems from a new centre and software SNAFUs. The company said...

The share market closed at a ten-week high as blue-chip healthcare, banking and consumer stocks took the lead during a pause in a two-week commodities rally.   The S&P/ASX 200 climbed 52 points or 0.7 per cent to its strongest close...

Tech stocks took up the running as the Australian share market rose for a sixth session ahead of tonight’s Federal Budget. The S&P/ASX 200 climbed 59 points or 0.8 per cent to its highest since mid-January. The I.T. sector jumped...

World Overnight SPI Overnight 7415.00 + 38.00 0.52% S&P ASX 200 7412.40 + 6.20 0.08% S&P500 4575.52 + 32.46 0.71% Nasdaq Comp 14354.90 + 185.60 1.31% DJIA 34955.89 + 94.65 0.27% S&P500 VIX 19.63 – 1.18 – 5.67% US...

The ASX was set to open higher for a sixth session following gains on Wall Street as oil retreated and Russia and Ukraine prepared to resume peace talks. ASX futures rallied 38 points or 0.52 per cent, pointing to further gains from a ra...

The share market was poised to open higher for a fifth session following gains in key commodities and a mixed finish on Wall Street. ASX futures advanced 33 points or 0.45 per cent.  Rallies in iron ore and oil helped offset a choppy...

ShareCafeDiary: A Good Time to Take Stock While the federal budget dominates business, markets and economic matters this week in Australia, globally it will be a combination of the March US jobs report and the final surveys of business acti...

ShareCafeMarket Morsels: QUB, API We’re not going to lie to you – Monday was about as quiet a news day as you’ll see on the ASX. Nice to be able to catch one’s breath with everything that’s been going on both locally and globally, but not s...

ShareCafeDiary: Through the Looking-Glass For what would normally be a quiet week for markets and economic news – well, apart from the continuing assault on Ukraine by Vladimir Putin and his armed forces and the impact that is having on all...

ShareCafeThe Week that Was – February 28-March 4, 2022 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

ShareCafeSIG – Credit Suisse rates the stock as Neutral Demand for rapid antigen tests has seen Sigma Healthcare upgrade its earnings guidance range to 10-15% year-on-year growth, which Credit Suisse notes implies a $20m earnings benefit si...

President Biden delivered his annual State of the Union address during the session, with strong commentary around Ukraine and targeted investment into domestic manufacturing capacity supporting US futures and ultimately pushing the S&P/...

ShareCafeSigma Ups Guidance on Rapid Antigen Test Demand Higher sales of RATs (Rapid Antigen Tests) has seen pharmaceuticals wholesaler Sigma Healthcare upgrade its January 31 financial year earnings. The news saw the shares jump more 4% at...

Highlights  The ASX 200 closed 0.3% higher, up 20.2 points to 7116.7 with most sectors lower aside from mining and energy stocks. Geopolitical tensions escalated as Russia further advanced its invasion of Ukraine. Crude oil prices sur...

The major miners dug the share market out of a hole after soaring commodity prices helped drive Wall Street sharply lower overnight. The S&P/ASX 200 fell 55 points in early action before a commodities-led rebound. The Australian benc...

02 Mar 2022 - Sigma Healthcare (ASX:SIG) has upgraded its earnings guidance for the year ending January 31 following a demand for Covid-19 related products.

Australia’s status as a commodities world-leader helped shield it from pressure on financial markets as surging commodity prices sharpened inflationary worries. Gains in miners and oil producers helped the S&P/ASX 200 advance 16 poin...

Highlights The benchmark ASX 200 index fell 0.68% to 7,047 in the first 15 minutes of morning trade. Brent crude oil surged past US$107 per barrel on Tuesday. The market is having a bearish tilt today with nine out of the 11 sectors t...

The ASX 200 Health Index (XHJ) is trading lower by 0.27% at the time of writing, compared to the broader index which is falling by 0.56%. Pain relief specialist Medical Development International (ASX:MVP) announced that the US FDA has uncon...

The Sigma Healthcare Ltd (ASX: SIG) share price is going up after upgrading its profit guidance for FY22. Sigma is a pharmacy and distribution business. The Amcal pharmacy business is a key profit generator for the company. Sigma’s profit u...

At the time of writing, the ASX 200 Health Index (XHJ) is down 2%, while the benchmark ASX 200 is also falling by 0.75%. The path is now open for pharma distributor Australian Pharmaceutical Industries (ASX: API) to be acquired by Wesfarmer...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The Wesfarmers Ltd (ASX: WES) share price performed well through 2021. After ending 2020 trading at $50.40, the company’s share price rose to close 2021 at $59.30. That means the retail conglomerate gained 17.66% last year, recording a hig...

It’s been a wild rise for market watchers interested in Wesfarmers Ltd‘s (ASX: WES) takeover of Australian Pharmaceuticals Industries Ltd (ASX: API). The company’s bid has been blindsided twice, once by Sigma Healthcare Ltd (ASX: SIG) and...

Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its non-binding proposal for Priceline owner Australian Pharmaceutical Industries Ltd (ASX: API). Subsequently, the API share price has tumbled 12.43% in morning trade to $1.5...

Paragon Care (PGC) has appointed Mark Hooper as group chief executive officer (CEO) and managing director of the company Mark Hooper is the current CEO of Sigma Healthcare, announcing his tendered resignation after almost 11 years Over the...

The Sigma Healthcare Ltd (ASX: SIG) share price has had a disappointing month, falling by more than 14% so far. This comes after the pharmacy chain operator and distributor provided investors with a trading update earlier in December. At t...

What a year it’s been for the Australian healthcare sector in 2021. It has had to come to grips with the lasting effects of COVID-19, and has experienced a wave of disruption and innovation at levels not seen before. Meanwhile, surging cas...

ShareCafeThe Week that Was – December 6-10, 2021 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so...

World Overnight SPI Overnight 7368.00 – 10.00 – 0.14% S&P ASX 200 7384.50 – 20.90 – 0.28% S&P500 4667.45 – 33.76 – 0.72% Nasdaq Comp 15517.37 – 269.62 – 1.71% DJIA 35754.69 – 0.06 – 0.00% S&P500 VIX 21.58 + 1.68 8....

ShareCafeEBOS Goes to Market to Fund Expansion NZ healthcare and pet food group EBOS seems to have ruled itself out of any role in the restructuring of the highly protected Australian pharmacy sector that emerged in late November when Woolw...

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.5% to 7,426 points. Four ASX shares that have failed to follow the market higher today are listed...

World Overnight SPI Overnight 7376.00 + 22.00 0.30% S&P ASX 200 7313.90 + 68.80 0.95% S&P500 4686.75 + 95.08 2.07% Nasdaq Comp 15686.92 + 461.76 3.03% DJIA 35719.43 + 492.40 1.40% S&P500 VIX 21.89 – 5.29 – 19.46%...

ShareCafeSIG – Citi rates the stock as Neutral Following a trading update by Sigma Healthcare, Citi reduces FY22-24 EPS forecasts by -24%, -15% and -2%, respectively and lowers its target price to $0.50 from $0.60. The Neutral rating is unc...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of Wall Street and is on track to record a strong gain. In afternoon trade, the benchmark index is up 1% to 7,320.5 points. Four ASX shares that have failed to follow the market hi...

The S&P/ASX 200 (ASX: XJO) managed to eke out a tiny gain of just 4 points on Monday, overcoming a mixed overseas lead. ASX BNPL rout sinks market This was despite significant selling pressure facing the technology sector, but more spec...

ShareCafeMarket Murmurs: SIG, BLD It’s been a ‘big’ five weeks or so for Sigma Healthcare and a 52-week low for the shares yesterday capped off what has turned out to be a boom-and-bust period. Just over a month ago, Sigma was briefly a wan...